secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2022-04-05T23:59:59+00:00
Accession:  0000885725-22-000009
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific EVP David Pierce to retire; Butcher and Jones to assume new roles
--------------------------------------------------------------------------------

- David A. Pierce, EVP and president MedSurg & Endoscopy, retiring effective July 4, 2022.
- Arthur C. Butcher becomes EVP and group president MedSurg & Asia Pacific effective May 2, 2022.
- Michael Jones becomes SVP and president Endoscopy effective May 2, 2022.
- Pierce joined in 1991 and will lead transition of responsibilities until retirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572522000009/0000885725-22-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572522000009/bsx-20220330.htm
  HTML page:      https://secwatch.observer/filing/0000885725-22-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer